On 3rd and 4th February 2022, the CRASH organised a workshop aimed principally at the directors and operational managers of MSF Operational Centre Paris (OCP) to reflect on current debates, and to determine which elements of the discussion would be the most relevant to resolve to support the advancement of MSF OCP’s operational projects. Is access to medicines the same issue today as it was when MSF first became interested in the mid-1990s? Rather than just concentrating on the obstacles to accessing medicines, should the debate be broadened to encompass what are now called ‘health products’ or even further, towards access to care and thus largely structural problems of human resources, financing, or the absence of national health insurance policies?

Entretien publié dans le journal La Croix le 25 Mai 2021.

Dans cet entretien pour le journal La Croix, Philippe Solano, généticien, et Jean-Hervé Bradol, ancien président de Médecins Sans Frontières et membre du CRASH, font le point sur l’avancée de la lutte contre les maladies tropicales.

The Drugs for Neglected Diseases initiative (DNDi) and other researchers, including MSF-Crash Dr. Jean Hervé Bradol, report a persistent deficiency in truly new therapeutics for neglected diseases, despite nominal progress and an acceleration in research and development (R&D) efforts. 

A l'aide de rappels historiques et d'exemples concrets, Rony Brauman analyse les responsabilités respectives des divers acteurs (laboratoires, gouvernements, institutions, ONG) dans le déficit d'accès aux soins.